Need Help?
Copied to clipboard!

Longitudinal ctDNA profiling in in MGMT-silenced metastatic colorectal cancer ctDNA exome

This study elucidates how MGMT-silenced MSS colorectal cancers evolve under temozolomide and immunotherapy. ctDNA was isolated from serially collected plasma samples at baseline, post-TMZ induction, during immunotherapy and, when available, at disease progression. Changes in DNA sequence under these conditions were used to study which mutations may be driving tumour progression.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000002574 Illumina NovaSeq 6000 123